Skip to content
SPAC Feed

Curated SPACs News

site-advertisement
  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
1 min to read
  • S-1 Filing
Posted on March 14, 2023

S-1 – Allarity Therapeutics, Inc. (0001860657) (Filer)

Filed: 2023-03-14 AccNo: 0001213900-23-019717 Size: 840 KB
Source: S-1 – Allarity Therapeutics, Inc. (0001860657) (Filer)

  • share 
  • tweet 
  • share 
Tags: S-1 Filing

Post navigation

Don't Expect PSNY Stock to Regain a Full Charge – InvestorPlace
Cash-guzzling Arrival raises £250m – UKTN (UK Technology News

Trending Stories

  • e.GO's Registration Statement on Form F-4 in Connection With Its … – Business Wire
    e.GO's Registration Statement on Form F-4 in Connection With Its ...  Business Wire Source: e.GO's Registration Statement on Form F-4 in...
  • 26 Capital Acquisition Corp. Announces Liquidation – PR Newswire
    26 Capital Acquisition Corp. Announces Liquidation  PR Newswire Source: 26 Capital Acquisition Corp. Announces Liquidation - PR Newswire
  • Dissecting the Direct Listing Die-Out
    When weighing options for going public, savvy entrepreneurs sometimes consider using the Direct Listing method instead of opting for a...
  • Athena Consumer Acquisition Corp. Announces Extension of … – WDRB
    Athena Consumer Acquisition Corp. Announces Extension of ...  WDRB Source: Athena Consumer Acquisition Corp. Announces Extension of ... - WDRB
  • Demandbase Announces New Executive Hires with Industry … – PR Newswire
    Demandbase Announces New Executive Hires with Industry ...  PR Newswire Source: Demandbase Announces New Executive Hires with Industry ... - PR...

SPACs Twitter Feed

Twitter feed is not available at the moment.
  • 1
    • News

    Seven law firms act on VIE-structured CheChe's US de-SPAC - Law.asia

  • 2
    • News

    Scoop: Alto Pharmacy raises $120 million in new funding - Axios

  • 3
    • News

    Carousell says it's 'on track' to profitability, plans to reduce losses this year - CNBC


SPAC Feed | Subscribe to Newsletter
  • About Us
  • Contact Us
  • Subscribe
Copyright © 2023 SPAC Feed. All Rights Reserved.